Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $24.3 million.

  • Cumberland Pharmaceuticals' Total Current Liabilities fell 2180.15% to $24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.3 million, marking a year-over-year decrease of 2180.15%. This contributed to the annual value of $31.6 million for FY2024, which is 1300.64% up from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Total Current Liabilities is $24.3 million, which was down 2180.15% from $24.0 million recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Total Current Liabilities peaked at $31.6 million during Q4 2024, and registered a low of $17.9 million during Q3 2021.
  • In the last 5 years, Cumberland Pharmaceuticals' Total Current Liabilities had a median value of $25.3 million in 2022 and averaged $25.1 million.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Total Current Liabilities plummeted by 2503.36% in 2021, and later skyrocketed by 4824.36% in 2022.
  • Over the past 5 years, Cumberland Pharmaceuticals' Total Current Liabilities (Quarter) stood at $19.3 million in 2021, then surged by 48.24% to $28.6 million in 2022, then decreased by 2.09% to $28.0 million in 2023, then increased by 13.01% to $31.6 million in 2024, then dropped by 23.12% to $24.3 million in 2025.
  • Its Total Current Liabilities was $24.3 million in Q3 2025, compared to $24.0 million in Q2 2025 and $25.5 million in Q1 2025.